Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial

Recruiting N/A Interventional Study
Infant, Newborn, Diseases Prematurity Prematurity; Extreme Respiratory Distress Syndrome in Premature Infant
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 30 Minutes
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
164 (estimated)
Sponsor
University College Dublin · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn whether giving surfactant through a thin endotracheal catheter to extremely premature babies shortly after birth reduces the number of them who are ventilated in the first 3 days of life. The main question it aims to answer is: Do fewer babies who receive prophylactic thin catheter surfactant under video laryngoscopy shortly after birth go on to be ven…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria * Infants of any sex born before 28 weeks of gestation * Clinicians plan to provide intensive care * Consent for their participation provided by parent(s)/guardian(s) before their birth Exclusion criteria • Major congenital anomalies (e.g. upper airway anomaly, diaphragmatic he…
Contacts

Colm PF O'Donnell, MB PhD

35316373100

codonnell@nmh.ie

CONTACT